Aogin Video Rerun
Room A : FIDELLA
| Thursday, November 24 | |
| 10.15-10.30 | Opening Ceremony |
| 10.30-11.00 | Presidential Address |
| Wisit Supakarapongkul (decline to public) | |
| 11.00-12.00 | S1: Global & Asia-Oceania Policy on Cervical Cancer Elimination |
| QA | |
| 12.00-13.00 | Sponsor Lunch Symposium: Roche Diagnostics (Thailand) Ltd.) Enroute to Cervical Cancer Elimination: A Paradigm Shift to HPV DNA Testing |
| QA | |
| 13.00-14.00 | S2: Regional Guidelines of Cervical Cancer Screening |
| 14.30-15.15 | Sponsor Symposium: MP Group Beyond the Standard Primary HPV DNA Testing Algorithm for Cervical Cancer |
| 15.30-16.30 | S3: HPV Assays: Evidence & Clinical Application |
| 16.30-17.15 | T1: Case Scenario: Physicians’ & Patients’ Perspectives in Management of Cervical Lesions |
| Friday, November 25 | |
| 8.00-9.00 | Oral presentation: Vulva/Vagina/HPV Vaccine |
| Lily Wu #1 | |
| Jin oh Kim #1 | |
| Lily Wu #2 | |
| Lily Wu#3 | |
| Jin oh Kim #2 | |
| Didik Setiawan | |
| 9.00-10.00 | S4: Current Situations of HPV Vaccination |
| Suza | |
| Ryo | |
| Phili | |
| Sures | |
| 10.15-11.00 | S5: Single Dose HPV Vaccine |
| Neerj | |
| Debor | |
| Sucha | |
| 11.00-11.45 | S6: Management of Abnormal Cervical Cancer Screening in Different Settings |
| Jatu | |
| Jeffr | |
| Smit | |
| 11.45-12.45 | Sponsor Lunch Symposium: MSD (Thailand) Ltd. Pathing Toward Gender-neutral Vaccination |
| You | |
| Geo | |
| Wich | |
| 12.45-13.30 | S7: Current and Future Research in HPV Cancers |
| Ryo | |
| K | |
| D | |
| 13.30-14.15 | T3: Burden of HPV Infection and Related Lesions in Transgenders |
| Apichai Vasuratna | |
| 14.15-15.00 | Sponsor Symposium: Hong Kong Hybribio Ltd. Alternative Approach to Escalate HPV Detection |
| 15.15-16.00 | Interesting Cases: Vulva/vagina |
| Pattama Chaopotong | |
| Supreechaya Phansenee | |
| 16.00-16.45 | T5: Self-sampling: An Alternative or A Replacement |
| Saturday, November 26 | |
| 8.00-8.45 | T7: Roles of VIA in Cervical Cancer Screening in Asia- Oceania Region |
| QA | |
| 8.45-9.30 | T9: Current and Future Direction in Immunotherapy for HPV-Related Cervical Diseases |
| Apichai Vasuratna | |
| 9.45-10.30 | T11: Management of VIN & Vulvar Cancer |
| QA | |
| 10.30-11.15 | T13: AI & Innovative Cancer Screening |
Room B : FAUNA
| Thursday, November 24 | |
| 16.30-17.15 | T2: Highlights of WHO Classification of Female Lower Genital Tract Lesions |
| Friday, November 25 | |
| 8.00-9.00 | Oral presentation: Cervix |
| Th | |
| M | |
| | |
| Pic | |
| Y | |
| S | |
| 13.30-14.15 | T4: Clinical Application of Molecular Pathology & Biomarkers |
| 14.15-15.00 | Sponsor Symposium: Astra Zeneca (Thailand) Ltd. Dare to Challenge in HRD Associated Advanced Ovarian Cancer |
| 15.15-16.00 | Interesting Cases: Cervix |
| 16.00-16.45 | T6: AIN: Epidemiology, Screening, Diagnosis, and Management |
| Saturday, November 26 | |
| 8.00-8.45 | T8: Radical Trachelectomy in Early-Stage Cervical Cancer: Oncological and Pregnancy Outcomes |
| Perapong Inthasorn | |
| Young Tak Kim | |
| XiaohuaWu | |
| Takuma Fuji | |
| 8.45-9.30 | T10: Updated Guidelines for Treatment of Cervical Cancer |
| Kittipat Charoenkwan | |
| Suwanit Therasakvichya | |
| Hextan Ngan | |
| 9.45-10.30 | T12: Screening & Management of Lower Genital Tract Disease in HIV-infected Women |
| Jakkapan Khunnarong | |
| Fang-Hui Zhao | |
| Annette Sohn | |
| 10.30-11.15 | T14: Updated Treatment of Preinvasive Cervical Lesions |
| Nuttavut Kantathavorn | |
| Karen Chan | |